The establishment of EVISA is funded by the EU through
the Fifth Framework Programme (G7RT- CT- 2002- 05112).
Supporters of EVISA includes:
A solution of magnesium hydroxide with antacid and laxative properties.
Milk of magnesium exerts its antacid activity in low doses such that
all hydroxide ions that enter the stomach are used to neutralize
stomach acid. This agent exerts its laxative effect in higher doses so
that hydroxide ions are able to move from the stomach to the intestines
where they attract and retain water, thereby increasing intestinal
movement (peristalsis) and inducing the urge to defecate.